• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Potential negative effects of the free use of chloroquine to manage COVID-19 in Colombia.在哥伦比亚自由使用氯喹治疗新冠肺炎的潜在负面影响。
J Med Virol. 2020 Nov;92(11):2254-2256. doi: 10.1002/jmv.26059. Epub 2020 Jun 5.
2
COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help.COVID-19、氯喹再利用和心脏安全问题：手性或许有帮助。
Molecules. 2020 Apr 16;25(8):1834. doi: 10.3390/molecules25081834.
3
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.氯喹或羟氯喹预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 12;2(2):CD013587. doi: 10.1002/14651858.CD013587.pub2.
4
Is chloroquine or hydroxychloroquine useful in treating people with COVID-19, or in preventing infection in people who have been exposed to the virus?氯喹或羟氯喹对治疗新型冠状病毒肺炎患者或预防接触过该病毒的人感染是否有效？
Saudi Med J. 2021 Mar;42(3):342-343.
5
What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.（羟）氯喹对抗 COVID-19 无效的原因：细胞生物学的见解。
J Mol Cell Biol. 2021 Jul 6;13(3):175-184. doi: 10.1093/jmcb/mjab016.
6
Insights in Chloroquine Action: Perspectives and Implications in Malaria and COVID-19.氯喹作用的新认识：疟疾和 COVID-19 中的观点和启示。
Cytometry A. 2020 Sep;97(9):872-881. doi: 10.1002/cyto.a.24190. Epub 2020 Aug 21.
7
Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?在疟疾感染率较高的国家，2019冠状病毒病（COVID-19）的发病率是否较低？
Med Hypotheses. 2020 Jul;140:109756. doi: 10.1016/j.mehy.2020.109756. Epub 2020 Apr 22.
8
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.氯喹、羟氯喹和阿奇霉素用于治疗新型冠状病毒肺炎（SARS-CoV-2感染）时的安全性考量
CMAJ. 2020 Apr 27;192(17):E450-E453. doi: 10.1503/cmaj.200528. Epub 2020 Apr 8.
9
Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% Dangerous.为何您的患者认为羟氯喹和氯喹对新冠病毒病有90%的疗效是极其危险的。
J Clin Pharmacol. 2020 Aug;60(8):949-953. doi: 10.1002/jcph.1687. Epub 2020 Jul 1.
10
Chloroquine and its derivatives in the management of COVID-19: A scoping review.氯喹及其衍生物在COVID-19治疗中的应用：一项范围综述。
Biomedica. 2020 Oct 30;40(Supl. 2):80-95. doi: 10.7705/biomedica.5478.

引用本文的文献

1
Off-Label Use of Chloroquine and Hydroxychloroquine for COVID-19 Treatment in Africa Against WHO Recommendation.在非洲，违反世界卫生组织的建议将氯喹和羟氯喹用于治疗新冠肺炎的非标签用药情况。
Res Rep Trop Med. 2020 Sep 17;11:61-72. doi: 10.2147/RRTM.S269936. eCollection 2020.
2
An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies.SARS-CoV-2/COVID-19 的最新进展，特别参考其临床病理学、发病机制、免疫病理学和缓解策略。
Travel Med Infect Dis. 2020 Sep-Oct;37:101755. doi: 10.1016/j.tmaid.2020.101755. Epub 2020 May 30.

本文引用的文献

1
Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19.羟氯喹在美国 COVID-19 住院患者中的使用效果。
Med. 2020 Dec 18;1(1):114-127.e3. doi: 10.1016/j.medj.2020.06.001. Epub 2020 Jun 5.
2
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial.高剂量与低剂量磷酸氯喹作为辅助治疗对住院的严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染患者的影响：一项随机临床试验。
JAMA Netw Open. 2020 Apr 24;3(4):e208857. doi: 10.1001/jamanetworkopen.2020.8857.
3
Chloroquine and hydroxychloroquine in covid-19.氯喹和羟氯喹在2019冠状病毒病中的应用
BMJ. 2020 Apr 8;369:m1432. doi: 10.1136/bmj.m1432.
4
Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries.氯喹和羟氯喹在治疗伴有或不伴有糖尿病的2019冠状病毒病中的应用：一项系统检索及叙述性综述，特别提及印度和其他发展中国家
Diabetes Metab Syndr. 2020 May-Jun;14(3):241-246. doi: 10.1016/j.dsx.2020.03.011. Epub 2020 Mar 26.
5
Monitoring transmissibility and mortality of COVID-19 in Europe.监测欧洲 COVID-19 的传染性和死亡率。
Int J Infect Dis. 2020 Jun;95:311-315. doi: 10.1016/j.ijid.2020.03.050. Epub 2020 Mar 28.
6
Estimating Risk for Death from Coronavirus Disease, China, January-February 2020.估算 2020 年 1-2 月中国新冠肺炎死亡风险。
Emerg Infect Dis. 2020 Jun;26(6):1251-1256. doi: 10.3201/eid2606.200233. Epub 2020 Jun 17.
7
Malaria intensity in Colombia by regions and populations.哥伦比亚各地区和人群的疟疾强度。
PLoS One. 2018 Sep 12;13(9):e0203673. doi: 10.1371/journal.pone.0203673. eCollection 2018.
8
Malaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination.巴西、哥伦比亚、秘鲁和委内瑞拉的疟疾：疟疾控制与消除的当前挑战
Malar J. 2017 Jul 4;16(1):273. doi: 10.1186/s12936-017-1925-6.
9
Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.羟氯喹和氯喹在治疗系统性红斑狼疮、类风湿关节炎及相关疾病中的治疗和药理学特性。
Inflammopharmacology. 2015 Oct;23(5):231-69. doi: 10.1007/s10787-015-0239-y. Epub 2015 Aug 6.
10
Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements.氯喹的临床药代动力学与代谢。聚焦于近期进展。
Clin Pharmacokinet. 1996 Oct;31(4):257-74. doi: 10.2165/00003088-199631040-00003.

Potential negative effects of the free use of chloroquine to manage COVID-19 in Colombia.

作者信息

Teherán Aníbal A, Camero Gabriel, Hernández Carolina, Perez-Garcia Luis, Gúzman Renato, Paniz-Mondolfi Alberto, Ramírez Juan David

机构信息

Red Cross Section Bogotá, Bogotá, Cundinamarca, Colombia.

Fundación Universitaria Juan N. Corpas, Bogotá, Colombia.

出版信息

J Med Virol. 2020 Nov;92(11):2254-2256. doi: 10.1002/jmv.26059. Epub 2020 Jun 5.

DOI:10.1002/jmv.26059
PMID:32458488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7283679/
Abstract
摘要